# Zhao Hu

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/zhao-hu/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,909 |
| Field | Chronic Kidney Disease and Diabetes |
| h-index | 17 |
| i10-index | 27 |
| Last Known Institution | Qilu Hospital of Shandong University |
| OpenAlex ID | https://openalex.org/A5100736506 |
| ORCID iD | 0000-0002-9998-0138 |
| Works | 62 |

## Researcher papers

- [Prevalence of chronic kidney disease in China: a cross-sectional survey](https://scholariq.org/papers/prevalence-of-chronic-kidney-disease-in-china-a-cross-sectional-survey/)
- [The green tea polyphenol (−)-epigallocatechin-3-gallate ameliorates experimental immune-mediated glomerulonephritis](https://scholariq.org/papers/the-green-tea-polyphenol-epigallocatechin-3-gallate-ameliorates-experimental/)
- [Epigallocatechin-3-gallate protects against cisplatin-induced nephrotoxicity by inhibiting endoplasmic reticulum stress-induced apoptosis](https://scholariq.org/papers/epigallocatechin-3-gallate-protects-against-cisplatin-induced-nephrotoxicity-by/)
- [Resveratrol attenuates acute kidney injury by inhibiting death receptor-mediated apoptotic pathways in a cisplatin-induced rat model](https://scholariq.org/papers/resveratrol-attenuates-acute-kidney-injury-by-inhibiting-death-receptor-mediated/)
- [Distinguishable Immunologic Characteristics of COVID-19 Patients with Comorbid Type 2 Diabetes Compared with Nondiabetic Individuals](https://scholariq.org/papers/distinguishable-immunologic-characteristics-of-covid-19-patients-with-comorbid/)
- [Epigallocatechin-3-gallate protects against cisplatin nephrotoxicity by inhibiting the apoptosis in mouse.](https://scholariq.org/papers/epigallocatechin-3-gallate-protects-against-cisplatin-nephrotoxicity-by/)
- [The associations of plant-based protein intake with all-cause and cardiovascular mortality in patients on peritoneal dialysis](https://scholariq.org/papers/the-associations-of-plant-based-protein-intake-with-all-cause-and-cardiovascular/)
- [Efficacy and Safety of Niaoduqing Particles for Delaying Moderate-to-severe Renal Dysfunction](https://scholariq.org/papers/efficacy-and-safety-of-niaoduqing-particles-for-delaying-moderate-to-severe/)
- [A noncoding RNA regulates human protease-activated receptor-1 gene during embryogenesis](https://scholariq.org/papers/a-noncoding-rna-regulates-human-protease-activated-receptor-1-gene-during/)
- [Relationship Between Psychiatric Disorders and Quality of Life in Nondialysis Patients With Chronic Kidney Disease](https://scholariq.org/papers/relationship-between-psychiatric-disorders-and-quality-of-life-in-nondialysis/)
- [Development and validation of nomogram and machine learning models to predict sarcopenia in patients with chronic kidney disease](https://scholariq.org/papers/development-and-validation-of-nomogram-and-machine-learning-models-to-predict/)

## Researcher topics

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Chemotherapy-induced organ toxicity mitigation](https://scholariq.org/topics/chemotherapy-induced-organ-toxicity-mitigation/)

## Researcher university

- [Qilu Hospital of Shandong University](https://scholariq.org/institutions/qilu-hospital-of-shandong-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.